In this study, we demonstrate the use of ROS‐responsive and PD‐L1‐targeted nano‐enabled chemotherapy for robust ICD induction in a xenograft 4T1 breast cancer model, an outcome that was not well exerted by free DOX. This evidence concerns the gene CD274 and breast carcinoma.